Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

158401-51-5Cyclophosphamide Related Compound D

● In Stock

Catalogue No.:	VL165002
CAS No.:	158401-51-5
Mol. Formula:	C7H20Cl3N2O4P
Mol. Weight:	333.58 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 158401-51-5

Parent drug

Cyclophosphamide

IUPAC Name

3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride

Synonyms

3-[[2-[(2-Chloroethyl)amino]ethyl]amino]-1-propanol Dihydrogen Phosphate Dihydrochloride; Cyclophosphamide Impurity D Dihydrochloride; USP Cyclophosphamide Related Compound D;

Description

Cyclophosphamide Related Compound D (CAS No.: 158401-51-5) or 3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride is a metabolite of the compound Cyclophosphamide. Cyclophosphamide is a phonetically active agent and is extensively evaluated for the treatment of an array of malignant and nonmalignant disorders. Even though it has a few tumor selectivities, it also has a broad spectrum of toxicities.

References

Joqueviel, Claire, et al. Urinary Excretion of Cyclophosphamide in Humans, Determined by Phosphorus-31 Nuclear Magnetic Resonance Spectroscopy. Drug Metabolism and Disposition, vol. 26, no. 5, American Society for Pharmacology and Experimental Therapeutics, May 1998, pp. 418â€“28, dmd.aspetjournals.org/content/26/5/418.short. ?Fraiser, Lucy H., et al. Cyclophosphamide Toxicity. Drugs, vol. 42, no. 5, Nov. 1991, pp. 781â€“95, doi.org/10.2165/00003495-199142050-00005.?